Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00667407 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in Asthma
A Phase 3 study, sponsored by Sumitomo Pharma America.
- Completed
- Registry status
- Phase 3
- Development phase
- 627
- Enrollment target
NCT00667407: Completed Phase 3 study, sponsored by Sumitomo Pharma America.
NCT00667407 is a Phase 3 study that has completed, run by Sumitomo Pharma America. The registered enrollment target is 627 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (19% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00667407, a Phase 3 study, has completed, sponsored by Sumitomo Pharma America.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 627 participants
- Enrollment target
Study Summary
To investigate the Efficacy and Safety of Levalbuterol versus Racemic Albuterol in the Treatment of Acute Asthma.
Interventions
- DRUG Levalbuterol 1.25 mg
- DRUG Racemic Albuterol Sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 627 participants |
| Start Date | 2000-11 |
| Est. Completion | 2002-08 |
| Phase | Phase 3 |
What the finished NCT00667407 record still lists
NCT00667407 is an interventional study that assigns participants to a tested intervention. The registered 627 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (19% lower).
The record links to 0 conditions, and to 2 interventions - of which Levalbuterol 1.25 mg is the first listed.
NCT00667407 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00667407 about?
NCT00667407 is a clinical study titled "Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in Asthma". To investigate the Efficacy and Safety of Levalbuterol versus Racemic Albuterol in the Treatment of Acute Asthma.
What is the current status of trial NCT00667407?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 627 participants. The study started on 2000-11. Estimated completion is 2002-08.
What interventions are being tested in trial NCT00667407?
The interventions under investigation include: Levalbuterol 1.25 mg (DRUG), Racemic Albuterol Sulfate (DRUG).
Who is sponsoring clinical trial NCT00667407?
This trial is sponsored by Sumitomo Pharma America, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00667407's enrollment target sits among peer trials
627 586th of 2000 higher than 1,415 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06040827 · 626 participants
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension
- NCT05349227 · 625 participants · NA
Comprehensive Outcomes for After Cancer Health
- NCT06103864 · 625 participants · Phase 3
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
- NCT06230510 · 625 participants · NA
Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia